Last week, Angelina Jolie's announcement of her preventive bilateral mastectomy and breast reconstruction, after finding out she carried the BRCA1 breast cancer gene, was met with mostly positive reaction. But some questioned whether this information was helpful or would just result in a surge of young women requesting genetic testing, which is not recommended for everyone and may result in unnecessary financial, emotional and possibly physical costs to pay.
I'm no stranger to controversial discussions around breast cancer. After my own mastectomy I came to understand that (my diagnosis) ductal carcinoma in situ (DCIS), can be a source of heated conversation for many people, particularly for DCIS patients and those women who have been diagnosed with invasive breast cancer.



